
GraniteShares YieldBoost HIMS ETF
HMYY
Updated: 25/09/2026, 07:37:49
The Fund's primary objective is to generate income equivalent to two times (200%) that derived from selling options linked to Hims & Hers Health, Inc. (NASDAQ: HIMS) (the "Underlying Stock"). This is achieved by writing options on a leveraged exchange-traded fund (the "Underlying Leveraged ETF") that itself targets twice (200%) the daily performance of the Underlying Stock. A secondary goal is to provide investors with exposure to the performance of this Underlying Leveraged ETF, albeit with a ceiling on potential investment returns. Furthermore, the Fund may implement measures for downside protection, a factor that could influence its ultimate net income.
No summaries found.
- Share price
- $5.48
- Market cap
- $3.19B
- Exchange
- NASDAQ
- Currency
- USD
- CEO
- Michael Kovacs
- Employees
- N/A
- IPO date
- 02/12/2025
- Beta
- 0.643
- Last dividend
- $0.00
- Day range
- $5.37 – $5.48
- 52-week range
- $5.27 – $25.79
- 1-day performance
- 0.66%
- 1-year performance
- 3.89%
- Current drawdown (1Y)
- -78.77%
- CIK
- 0001924868
- CUSIP
- 38747R140
- ISIN
- US38747R1409
- Created
- 07/12/2025, 04:33:59
- Last update
- 25/09/2026, 07:37:49
Track GraniteShares YieldBoost HIMS ETF with an AI analyst
See which prediction-market events move HMYY, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
No news found for this symbol.